Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
SB533 • 2025
Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs.
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
The plain English breakdown is still being put together. The official documents below are already here.
At President's desk upon adjournment.
Work Session held.
Public Hearing held.
Referred to Health Care.
Introduction and first reading. Referred to President's desk.
Digest: The Act bans drug makers from taking actions that make it hard for some drug outlets to get certain drugs on behalf of health care providers, deliver the drugs to the providers or dispense the drugs. The Act makes these actions subject to a civil penalty for violations. (Flesch Readability Score: 60.8). Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to submit utilization review data as a condition of acquiring, delivering or dispensing 340B drugs. Relating to: Relating to restrictions on 340B covered entities. Current location: At Presidents Desk Upon Adjournment